ProPhase Labs Inc (NAS:PRPH)
$ 5.12 0.07 (1.39%) Market Cap: 97.68 Mil Enterprise Value: 119.79 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 57/100

Q3 2021 Prophase Labs Inc Earnings Call Transcript

Nov 12, 2021 / 04:00PM GMT
Release Date Price: $5.71 (-1.38%)
Operator

Welcome to the ProPhase Labs's third-quarter 2021 financial results and corporate update conference call. (Operator Instructions)

Please note this event is being recorded. I would now like to turn the conference over to Jules Abraham with CORE IR. Please go.

Jules Abraham
CORE IR - IR

Thank you, Aileen. And good morning, everyone. During this call, management will be making forward-looking statements, including statements that address ProPhase's expectations for future performance or operational results. These include statements regarding the company's expectations with respect to Q4 COVID-19 testing revenues, its goal to build a sizable customer base of independent pharmacies that will provide consistent and growing testing revenues for its diagnostics business, plans to provide genomics testing with faster turnaround times and lower price points, and ongoing efforts to evaluate and pursue additional strategic and synergistic acquisitions to build the company's precision medicine and genomics research capabilities.

Forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot